Alembic Pharma recieves USFDA approval for Lacosamide
Alembic Pharmaceuticals Ltd has received final USFDA approval for its Lacosamide tablets, which is indicated as adjunctive therapy in patients with partial onset seizures. The […]
Uncategorized
Claris Lifesciences receives USFDA approval for Tobramycin
Claris Lifesciences has received USFDA approval for generic Tobramycin injection used for the treatment of bacterial infections. The estimated market size of the product in […]
Aurobindo Pharma receives USFDA approval for Fenofibrate
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets which are used for the treatment of high level of […]
Sun Pharmaceuticals receives USFDA approval for BromSite
Sun Pharmaceutical Industries has received final USFDA approval for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery. […]
Glenmark Pharmaceuticals receives USFDA approval for bendamustine hydrochloride
Glenmark Pharmaceuticals has received USFDA final approval for bendamustine hydrochloride for injection, 25 mg/vial and 100 mg/vial, the therapeutic equivalent to the reference listed drug […]
Aurobindo Pharma receives USFDA approval for Rivastigmine Tartrate
Aurobindo Pharma has received final USFDA to manufacture and market Rivastigmine Tartrate Capsules USP which is used for the treatment of dementia disease, in the […]
Aurobindo Pharma receives USFDA approval for pantoprazole
Aurobindo Pharma has received final USFDA approval to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the […]
Zydus Cadila receives ANDA approval for Dextromphetamine
Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (ANDA) approval from the US FDA to market Dextroamphetamine […]
Aurobindo Pharma receives USFDA approval for valganciclovir
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Cadila Healthcare receives USFDA approval for Acylovir capsules
Cadila Healthcare has received USFDA approval for its anti-viral generic drug Acyclovir capsules Acyclovir capsules to market the same in the American market. The drug […]